Singapore markets close in 1 hour 42 minutes

Straits Times Index
3,336.87
+4.07(+0.12%)
Nikkei
39,631.06
+47.98(+0.12%)
Hang Seng
17,718.61
+2.11(+0.01%)
FTSE 100
8,221.61
+57.49(+0.70%)
Bitcoin USD
63,363.13
+1,738.83(+2.82%)
CMC Crypto 200
1,313.39
+11.32(+0.87%)

HALO Jul 2024 55.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

3.1400

0.0000

(0.00%)

As of 11:43AM EDT. Market open.

Loading interactive chart…

Zacks
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PR Newswire
Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Roche received European Commission (EC) marketing authorization of OCREVUS® (ocrelizumab) SC co-formulated with ENHANZE®, Halozyme's proprietary recombinant human hyaluronidase enzyme, rHuPH20, for the treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).
Simply Wall St.
Halozyme Therapeutics (NASDAQ:HALO) shareholder returns have been stellar, earning 193% in 5 years
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...